Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2011

01-06-2011 | Editorial

Is traction the cause or the effect?

Author: David Wong

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2011

Login to get access

Excerpt

The role of vitreomacular traction in the pathogenesis of many macular conditions has generated much interest, not least because spectral-domain optical coherence tomography (SD-OCT) has enabled us to examine the vitreoretinal interface with higher resolution, in 3 dimensions and from different perspectives. In this issue, Martinez and Ophir add another condition, that of macular oedema following retinal vein occlusion, to the already long list of macular diseases in which vitreous plays a putative role [1] . In a retrospective and observational study, the authors found nine of 22 patients (five of 11 with CRVO and four of 11 with BRVO) had what they called extrafoveal traction. …
Literature
1.
go back to reference Martinez MR, Ophir A. (2011) Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography [in press—add DOI number when available] Martinez MR, Ophir A. (2011) Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography [in press—add DOI number when available]
2.
go back to reference Spiritus A, Dralands L, Stalmans P, Stalmans I, Spileers W (2000) OCT study of fellow eyes of macular holes. Bull Soc Belge Ophtalmol 275:81–84PubMed Spiritus A, Dralands L, Stalmans P, Stalmans I, Spileers W (2000) OCT study of fellow eyes of macular holes. Bull Soc Belge Ophtalmol 275:81–84PubMed
3.
go back to reference Thomas D, Bunce C, Moorman C, Laidlaw AH (2005) Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation, and subretinal fluid in patients with diabetic macular edema. Retina 25(7):883–888PubMedCrossRef Thomas D, Bunce C, Moorman C, Laidlaw AH (2005) Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation, and subretinal fluid in patients with diabetic macular edema. Retina 25(7):883–888PubMedCrossRef
4.
go back to reference Stefánsson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247(2):147–163PubMedCrossRef Stefánsson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247(2):147–163PubMedCrossRef
5.
go back to reference Kenawy N, Wong D, Stappler T, Romano MR, Das RA, Hebbar G, Prime W, Heimann H, Gibran SK, Sheridan CM, Cheung YH, Hiscott PS (2010) Does the presence of an epiretinal membrane alter the cleavage plane during internal limiting membrane peeling? Ophthalmology 117(2):320–323PubMedCrossRef Kenawy N, Wong D, Stappler T, Romano MR, Das RA, Hebbar G, Prime W, Heimann H, Gibran SK, Sheridan CM, Cheung YH, Hiscott PS (2010) Does the presence of an epiretinal membrane alter the cleavage plane during internal limiting membrane peeling? Ophthalmology 117(2):320–323PubMedCrossRef
6.
go back to reference Ophir A, Trevino A, Martinez MR (2010) Extrafoveal vitreous traction associated with branch retinal vein occlusion. Eur J Ophthalmol 20(4):733–739PubMed Ophir A, Trevino A, Martinez MR (2010) Extrafoveal vitreous traction associated with branch retinal vein occlusion. Eur J Ophthalmol 20(4):733–739PubMed
7.
go back to reference Sakuma T, Mizota A, Inoue J, Tanaka M (2010) Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 150(6):876–882PubMedCrossRef Sakuma T, Mizota A, Inoue J, Tanaka M (2010) Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 150(6):876–882PubMedCrossRef
8.
go back to reference Park DH, Kim IT (2010) Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 30(1):117–124PubMedCrossRef Park DH, Kim IT (2010) Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 30(1):117–124PubMedCrossRef
9.
go back to reference Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH (2009) Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol 247(8):1019–1023PubMedCrossRef Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH (2009) Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol 247(8):1019–1023PubMedCrossRef
10.
go back to reference Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C, Lauer AK, Peters MA, Stockman ME (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(6):1087–1093PubMedCrossRef Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C, Lauer AK, Peters MA, Stockman ME (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117(6):1087–1093PubMedCrossRef
11.
go back to reference Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators (2010) Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(6):1124–1133PubMedCrossRef Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators (2010) Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(6):1124–1133PubMedCrossRef
12.
go back to reference Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, BRAVO Investigators (2010) Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(6):1102–1112PubMedCrossRef Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, BRAVO Investigators (2010) Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(6):1102–1112PubMedCrossRef
13.
go back to reference Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6):1134–1114PubMedCrossRef Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6):1134–1114PubMedCrossRef
Metadata
Title
Is traction the cause or the effect?
Author
David Wong
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2011
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1665-1

Other articles of this Issue 6/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2011 Go to the issue